Invention Grant
- Patent Title: Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy
-
Application No.: US17225854Application Date: 2021-04-08
-
Publication No.: US11617773B2Publication Date: 2023-04-04
- Inventor: Xavier Duportet , Cristina del Carmen Gil-Cruz , Christian Ivan Pérez-Shibayama , Burkhard Ludewig
- Applicant: Eligo Bioscience , Kantonsspital St.Gallen
- Applicant Address: FR Paris; CH St.Gallen
- Assignee: Eligo Bioscience,Kantonsspital St.Gallen
- Current Assignee: Eligo Bioscience,Kantonsspital St.Gallen
- Current Assignee Address: FR Paris; CH St.Gallen
- Agency: Arrigo, Lee, Guttman & Mouta-Bellum LLP
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A01N63/00 ; C07H21/04 ; A61K35/76 ; C12N9/22 ; A61K31/7036 ; A61K31/505 ; A61K38/14 ; A61K31/4164 ; A61K31/635 ; A61K31/7056

Abstract:
The invention relates to methods, kits and compositions for reducing the level of or eliminating Bacteroides in situ. The invention encompasses methods of preventing myocarditis, treating myocarditis or dilated cardiomyopathy, or limiting progression of myocarditis toward dilated cardiomyopathy in a subject in need thereof, comprising reducing the amount of Bacteroides sp. in the subject. The invention further encompasses methods of diagnosis of a subject as having myocarditis or dilated cardiomyopathy. The invention also encompasses compositions preventing myocarditis, treating myocarditis or dilated cardiomyopathy, or limiting progression of myocarditis toward dilated cardiomyopathy in a subject in need thereof.
Public/Granted literature
- US20210315950A1 ELIMINATION OF COLONIC BACTERIAL DRIVING LETHAL INFLAMMATORY CARDIOMYOPATHY Public/Granted day:2021-10-14
Information query